These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
492 related articles for article (PubMed ID: 19091901)
1. Does 18F-FDG PET/CT improve the detection of posttreatment recurrence of head and neck squamous cell carcinoma in patients negative for disease on clinical follow-up? Abgral R; Querellou S; Potard G; Le Roux PY; Le Duc-Pennec A; Marianovski R; Pradier O; Bizais Y; Kraeber-Bodéré F; Salaun PY J Nucl Med; 2009 Jan; 50(1):24-9. PubMed ID: 19091901 [TBL] [Abstract][Full Text] [Related]
2. FDG-PET/contrast-enhanced CT as a post-treatment tool in head and neck squamous cell carcinoma: comparison with FDG-PET/non-contrast-enhanced CT and contrast-enhanced CT. Suenaga Y; Kitajima K; Ishihara T; Sasaki R; Otsuki N; Nibu K; Minamikawa T; Kiyota N; Sugimura K Eur Radiol; 2016 Apr; 26(4):1018-30. PubMed ID: 26188656 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic performance of FDG PET/CT to detect subclinical HNSCC recurrence 6 months after the end of treatment. Robin P; Abgral R; Valette G; Le Roux PY; Keromnes N; Rousset J; Potard G; Palard X; Marianowski R; Salaun PY Eur J Nucl Med Mol Imaging; 2015 Jan; 42(1):72-8. PubMed ID: 25169701 [TBL] [Abstract][Full Text] [Related]
4. Screening for distant metastases before salvage surgery in patients with recurrent head and neck squamous cell carcinoma: a retrospective case series comparing thoraco-abdominal CT, positron emission tomography and abdominal ultrasound. Fakhry N; Michel J; Colavolpe C; Varoquaux A; Dessi P; Giovanni A Clin Otolaryngol; 2012 Jun; 37(3):197-206. PubMed ID: 22520870 [TBL] [Abstract][Full Text] [Related]
5. Local recurrence of squamous cell carcinoma of the head and neck after radio(chemo)therapy: Diagnostic performance of FDG-PET/MRI with diffusion-weighted sequences. Becker M; Varoquaux AD; Combescure C; Rager O; Pusztaszeri M; Burkhardt K; Delattre BMA; Dulguerov P; Dulguerov N; Katirtzidou E; Caparrotti F; Ratib O; Zaidi H; Becker CD Eur Radiol; 2018 Feb; 28(2):651-663. PubMed ID: 28812148 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic Performance of Clement C; Leclère JC; Maheo C; Le Pennec R; Le Gal G; Delcroix O; Robin P; Rousset J; Tissot V; Gueguen A; Allio M; Bourbonne V; Schick U; Marianowski R; Salaun PY; Abgral R J Nucl Med; 2024 Aug; 65(8):1181-1187. PubMed ID: 38991750 [TBL] [Abstract][Full Text] [Related]
7. 18F-FDG PET/CT for detecting distant metastases in patients with recurrent head and neck squamous cell carcinoma. Yi JS; Kim JS; Lee JH; Choi SH; Nam SY; Kim SY; Roh JL J Surg Oncol; 2012 Nov; 106(6):708-12. PubMed ID: 22674652 [TBL] [Abstract][Full Text] [Related]
8. Clinical utility of 18F-FDG PET/CT in assessing the neck after concurrent chemoradiotherapy for Locoregional advanced head and neck cancer. Ong SC; Schöder H; Lee NY; Patel SG; Carlson D; Fury M; Pfister DG; Shah JP; Larson SM; Kraus DH J Nucl Med; 2008 Apr; 49(4):532-40. PubMed ID: 18344440 [TBL] [Abstract][Full Text] [Related]
9. Does 18fluoro-fluorodeoxyglucose positron emission tomography improve recurrence detection in patients treated for head and neck squamous cell carcinoma with negative clinical follow-up? Salaun PY; Abgral R; Querellou S; Couturier O; Valette G; Bizais Y; Kraeber-Bodéré F Head Neck; 2007 Dec; 29(12):1115-20. PubMed ID: 17636537 [TBL] [Abstract][Full Text] [Related]
10. Locoregional tumour evaluation of squamous cell carcinoma in the head and neck area: a comparison between MRI, PET/CT and integrated PET/MRI. Schaarschmidt BM; Heusch P; Buchbender C; Ruhlmann M; Bergmann C; Ruhlmann V; Schlamann M; Antoch G; Forsting M; Wetter A Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):92-102. PubMed ID: 26243264 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of 18F-FDG PET/CT and CT/MRI with histopathologic correlation in patients undergoing salvage surgery for head and neck squamous cell carcinoma. Kim SY; Kim JS; Yi JS; Lee JH; Choi SH; Nam SY; Cho KJ; Lee SW; Kim SB; Roh JL Ann Surg Oncol; 2011 Sep; 18(9):2579-84. PubMed ID: 21409485 [TBL] [Abstract][Full Text] [Related]
12. Kim SA; Roh JL; Kim JS; Lee JH; Lee SH; Choi SH; Nam SY; Kim SY Eur J Cancer; 2017 Feb; 72():62-70. PubMed ID: 28027517 [TBL] [Abstract][Full Text] [Related]
13. Clinical utility of Ha SC; Roh JL; Kim JS; Lee JH; Choi SH; Nam SY; Kim SY Acta Otolaryngol; 2019 Sep; 139(9):810-815. PubMed ID: 31274365 [No Abstract] [Full Text] [Related]
14. Effect of time-of-flight technique on the diagnostic performance of 18F-FDG PET/CT for assessment of lymph node metastases in head and neck squamous cell carcinoma. Li CY; Klohr S; Sadick H; Weiss C; Hoermann K; Schoenberg SO; Sadick M J Nucl Med Technol; 2014 Sep; 42(3):181-7. PubMed ID: 24970897 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic performance of Chaput A; Robin P; Podeur F; Ollivier M; Keromnes N; Tissot V; Nonent M; Salaün PY; Rousset J; Abgral R Laryngoscope; 2018 Feb; 128(2):378-385. PubMed ID: 28600822 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of head and neck cancer with 18F-FDG PET: a comparison with conventional methods. Kresnik E; Mikosch P; Gallowitsch HJ; Kogler D; Wiesser S; Heinisch M; Unterweger O; Raunik W; Kumnig G; Gomez I; Grünbacher G; Lind P Eur J Nucl Med; 2001 Jul; 28(7):816-21. PubMed ID: 11504077 [TBL] [Abstract][Full Text] [Related]
18. Volumetric comparison of positron emission tomography/computed tomography using 4'-[methyl-¹¹C]-thiothymidine with 2-deoxy-2-¹⁸F-fluoro-D-glucose in patients with advanced head and neck squamous cell carcinoma. Ito K; Yokoyama J; Miyata Y; Toyohara J; Okasaki M; Minamimoto R; Morooka M; Ishiwata K; Kubota K Nucl Med Commun; 2015 Mar; 36(3):219-25. PubMed ID: 25369751 [TBL] [Abstract][Full Text] [Related]
19. Response evaluation of cervical lymph nodes after chemoradiation in patients with head and neck cancer - does additional [18F]FDG-PET-CT help? Dejaco D; Uprimny C; Widmann G; Riedl D; Moser P; Arnold C; Steinbichler TB; Kofler B; Schartinger VH; Virgolini I; Riechelmann H Cancer Imaging; 2020 Sep; 20(1):69. PubMed ID: 32993805 [TBL] [Abstract][Full Text] [Related]
20. (18)F-FDG PET/CT surveillance at 3-6 and 12 months for detection of recurrence and second primary cancer in patients with head and neck squamous cell carcinoma. Kim JW; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY Br J Cancer; 2013 Dec; 109(12):2973-9. PubMed ID: 24149172 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]